CIBC ASSET MANAGEMENT INC – Vertex Pharmaceuticals Incorporated Transaction History
CIBC ASSET MANAGEMENT INC portfolio value:
$19.12M
portfolio value
CIBC ASSET MANAGEMENT INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.95% | 3.11K shares | 1.39M | $289.54 | 66.03K |
| Q2 2022 | share | Decrease | -6.90% | -4.66K shares | 93K | $281.79 | 62.92K |
| Q1 2022 | share | Decrease | -0.08% | -55 shares | 2.78M | $260.97 | 67.58K |
| Q4 2021 | share | Increase | +10.28% | 6.30K shares | 3.72M | $222.45 | 67.64K |
| Q3 2021 | share | Increase | +7.18% | 4.10K shares | -413K | $181.39 | 61.33K |
| Q2 2021 | share | Increase | +4.93% | 2.69K shares | -181K | $201.63 | 57.22K |
| Q1 2021 | share | Increase | +14.64% | 6.96K shares | 477K | $214.89 | 54.53K |
| Q4 2020 | share | Increase | +6.78% | 3.02K shares | -880K | $236.34 | 47.57K |
| Q3 2020 | share | Increase | +15.66% | 6.03K shares | 940K | $272.12 | 44.55K |
| Q2 2020 | share | Increase | +3.06% | 1.14K shares | 2.28M | $290.31 | 38.52K |
| Q1 2020 | share | Increase | +1.81% | 664 shares | 856K | $237.95 | 37.37K |
| Q4 2019 | share | Increase | +4.03% | 1.42K shares | 2.05M | $218.95 | 36.71K |
| Q3 2019 | share | Decrease | -0.52% | -183 shares | -526K | $169.42 | 35.29K |
| Q2 2019 | share | Increase | +2.86% | 987 shares | 161K | $183.38 | 35.47K |
| Q1 2019 | share | Decrease | -0.06% | -22 shares | 626K | $183.95 | 34.48K |
| Q4 2018 | share | Increase | +1.77% | 601 shares | -817K | $165.71 | 34.50K |
| Q3 2018 | share | Increase | +1.88% | 627 shares | 879K | $192.74 | 33.90K |
| Q2 2018 | share | Increase | +6.35% | 1.98K shares | 556K | $169.96 | 33.28K |
| Q1 2018 | share | Decrease | -0.78% | -247 shares | 373K | $162.98 | 31.29K |
| Q4 2017 | share | Decrease | -0.97% | -310 shares | -116K | $149.86 | 31.54K |
| Q3 2017 | share | Increase | +2.05% | 641 shares | 821K | $152.04 | 31.85K |
| Q2 2017 | share | Increase | +3.23% | 977 shares | 716K | $128.87 | 31.21K |
| Q1 2017 | share | Increase | +1.79% | 531 shares | 1.11M | $109.35 | 30.23K |
| Q4 2016 | share | Increase | +1.42% | 415 shares | -366K | $73.67 | 29.70K |
| Q3 2016 | share | Decrease | -6.16% | -1.92K shares | -131K | $87.21 | 29.28K |
| Q2 2016 | share | Increase | +1.66% | 511 shares | 245K | $86.02 | 31.21K |
| Q1 2016 | share | Increase | +2.36% | 709 shares | -1.33M | $79.49 | 30.70K |